113 related articles for article (PubMed ID: 19726982)
1. Acyclovir: a new use for an old drug.
Vanpouille C; Lisco A; Margolis L
Curr Opin Infect Dis; 2009 Dec; 22(6):583-7. PubMed ID: 19726982
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
3. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
5. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus drug-resistance: new mutations and insights.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2013 Dec; 26(6):551-60. PubMed ID: 24152761
[TBL] [Abstract][Full Text] [Related]
7. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
8. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
Vogt M; Huss R; Wunderli W
Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.
Vanpouille C; Lisco A; Grivel JC; Bassit LC; Kauffman RC; Sanchez J; Schinazi RF; Lederman MM; Rodriguez B; Margolis L
Clin Infect Dis; 2015 Jun; 60(11):1708-14. PubMed ID: 25740794
[TBL] [Abstract][Full Text] [Related]
11. Empiric acyclovir for neonatal herpes simplex virus infection.
Vanderpluym C; Tawfik G; Hervas-Malo M; Lacaze-Masmonteil T; Kellner J; Robinson JL
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1278-82. PubMed ID: 21992471
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
13. HSV therapy and HIV-1 reduction.
Eisenhut M
N Engl J Med; 2007 May; 356(22):2323-4; author reply 2324. PubMed ID: 17542070
[No Abstract] [Full Text] [Related]
14. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
15. [Mother-infant and indirect transmission of HSV infection: treatment and prevention].
Henrot A
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
19. Antiviral agents for herpes simplex virus.
Vere Hodge RA; Field HJ
Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
McMahon MA; Siliciano JD; Kohli RM; Siliciano RF
AIDS; 2010 Jan; 24(2):319-23. PubMed ID: 20009920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
